Levodopa/Carbidopa/Entacapon Abz

Levodopa, carbidopa, entacapone, the active ingredient in Levodopa/Carbidopa/Entacapon Abz, is an Antiparkinson agent presented as an oral tablet for oral use. It is indicated for Parkinson's disease and for managing motor fluctuations in patients with Parkinson's disease. GNH USA supplies Levodopa/Carbidopa/Entacapon Abz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodopa/Carbidopa/Entacapone is used within the Parkinson's disease therapeutic pathway to improve motor control and reduce fluctuations. - Parkinson's disease: improves overall motor symptoms such as bradykinesia and rigidity. - Motor fluctuations in Parkinson's disease: reduces OFF periods and extends ON time. - Wearing‑off phenomenon: stabilises dopamine levels to smooth symptom control.

Levodopa/Carbidopa/Entacapone may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: often related to orthostatic blood pressure changes. - Headache: transient and usually resolves with continued therapy. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements that may be disabling. - Hallucinations: visual or auditory disturbances, especially in older patients. - Severe hypotension: sudden drop in blood pressure leading to fainting. - Neuroleptic malignant syndrome: rare but life‑threatening reaction with fever and muscle rigidity.

When prescribing Levodopa/Carbidopa/Entacapone, clinicians should consider several safety measures. - Blood pressure monitoring: watch for orthostatic hypotension, especially at treatment initiation. - Psychiatric assessment: evaluate for hallucinations, confusion, or mood changes. - Renal function: adjust dosing in patients with significant renal impairment. - Abrupt discontinuation: avoid sudden stop to prevent severe withdrawal symptoms. - Elderly patients: start at low dose and titrate slowly due to increased sensitivity. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Levodopa/Carbidopa/Entacapone can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - MAO‑B inhibitors: risk of hypertensive crisis or severe serotonin syndrome. - Non‑selective MAO inhibitors: may precipitate hypertensive emergencies. - Antipsychotics (dopamine antagonists): can markedly reduce therapeutic effect. - High‑protein meals: compete for transport across the blood‑brain barrier, diminishing levodopa absorption.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive blood‑pressure lowering effect. - SSRIs and other serotonergic agents: monitor for serotonin syndrome. - Other COMT inhibitors: increased risk of dopaminergic side effects.